Dipyrone (metamizole) metabolites interfere with HPLC analysis of plasma catecholamines but not with the determination of urinary catecholamines [4]

Clinical Chemistry

Volumn 52, Issue 9, 2006, Pages 1829-1831

  Müssig, Karsten ^a   Pfäfflin, Albrecht ^a   Häring, Hans Ulrich ^a   Schleicher, Erwin D ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYBENZYLAMINE; ADRENALIN; CATECHOLAMINE; DIPYRONE; DOPAMINE; DRUG METABOLITE; NORADRENALIN; NORAMIDOPYRINE;

CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE URINE LEVEL; CONTROLLED STUDY; DRUG CROSS REACTIVITY; DRUG HYDROLYSIS; DRUG URINE LEVEL; ELECTROCHEMICAL DETECTION; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LETTER; NEUROBLASTOMA; PHEOCHROMOCYTOMA; SENSITIVITY AND SPECIFICITY; STANDARD;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CATECHOLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIPYRONE; DOPAMINE; HUMANS; INDICATORS AND REAGENTS;

EID: 33748313086     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.071662     Document Type: Letter

References (12)

1. Schleicher ED, Kees FK, Wieland OH. Analysis of total urinary catecholamines by liquid chromatography: methodology, routine experience, and clinical interpretations of results. Clin Chim Acta 1983;129:295-302.
2. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002;287:1427-34.
3. Nakagawara A, Zaizen Y, Ikeda K, Suita S, Ohgami H, Nagahara N, et al. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas. J Cancer 1991;68:2037-44.
4. Arciero PJ, Gardner AW, Benowitz NL, Poehlman ET. Relationship of blood pressure, heart rate, and behavioral mood state to norepinephrine kinetics in younger and older men following caffeine ingestion. Eur J Clin Nutr 1998;52:805-12.
5. Smith D, Pernet A, Rosenthal JM, Bingham EM, Reid H, Macdonald IA, et al. The effect of modafinil on counter-regulatory and cognitive responses to hypoglycaemia. Diabetologia 2004;47:1704-11.
6. Fritsche A, Tschritter O, Hāring H, Gerich J, Stumvoll M. The role of β-adrenergic sensitivity in the pathogenesis of hypoglycaemia unawareness. Diabetes Nutr Metab 2002;15:357-61.
7. Holmes C, Eisenhofer G, Goldstein DS. Improved assay for plasma dihydroxyphenyl-acetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 1994;653:131-8.
8. Levy M, Flusser D, Zylber-Katz E, Granit L. Plasma kinetics of dipyrone metabolites in rapid and slow acetylators. Eur J Clin Pharmacol 1984;27:453-8.
9. Levy M, Zylber-Katz E, Rosenkranz B. Clinical pharmacokinetics of dipyrone and its metabolites. Clin Pharmacokinet 1995;28:216-34.
10. Wu AH, Gornet TG. Preparation of urine samples for liquid-chromatographic determination of catecholamines: bonded-phase phenylboronic acid, cation-exchange resin, and alumina adsorbents compared. Clin Chem 1985;31:298-302.
11. Davidson FD. Paracetamol-associated interference in an HPLC-ECD assay for urinary free metadrenalines and catecholamines. Ann Clin Biochem 2004;41:316-20.
12. Bouloux PM, Perrett D. Interference of labetalol metabolites in the determination of plasma catecholamines by HPLC with electrochemical detection. Clin Chim Acta 1985;150:111-7.